|
ATG2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.75159999999042E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.27589999998623E-06 |
| Normal-vs-Stage2 |
7.425600E-02 |
| Normal-vs-Stage3 |
1.317440E-03 |
| Normal-vs-Stage4 |
9.965200E-04 |
| Stage1-vs-Stage2 |
3.519600E-01 |
| Stage1-vs-Stage3 |
8.559800E-01 |
| Stage1-vs-Stage4 |
4.738000E-01 |
| Stage2-vs-Stage3 |
5.614400E-01 |
| Stage2-vs-Stage4 |
3.258400E-01 |
| Stage3-vs-Stage4 |
4.763400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54460000001411E-06 |
| Normal-vs-AfricanAmerican |
1.761090E-03 |
| Normal-vs-Asian |
3.589600E-02 |
| Caucasian-vs-AfricanAmerican |
3.915200E-01 |
| Caucasian-vs-Asian |
8.505400E-01 |
| AfricanAmerican-vs-Asian |
9.140000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76419999997623E-06 |
| Normal-vs-Female |
3.336300E-02 |
| Male-vs-Female |
1.050140E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.009200E-04 |
| Normal-vs-Extreme_Weight |
7.74300000006001E-07 |
| Normal-vs-Obese |
4.298100E-03 |
| Normal-vs-Extreme_Obese |
3.014800E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.593600E-01 |
| Normal_Weight-vs-Obese |
4.426200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.224000E-01 |
| Extreme_Weight-vs-Obese |
2.917700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.511400E-01 |
| Obese-vs-Extreme_Obese |
2.778000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.619000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.480930E-03 |
| Normal-vs-Age(61-80Yrs) |
1.8558000003388E-07 |
| Normal-vs-Age(81-100Yrs) |
2.165799999998E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.988040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.053900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.762040E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.180100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.130100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.360600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.370000E-04 |
| Normal-VS-Type2 PRCC |
4.25729995701118E-09 |
| Normal-VS-KIRP CIMP |
5.464000E-01 |
| Normal-VS-Unclassified PRCC |
1.026040E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.013500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.714800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.577600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.211030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.817620E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.576400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.77409999918754E-08 |
| Normal-vs-N1 |
1.170010E-01 |
| Normal-vs-N2 |
6.356800E-04 |
| N0-vs-N1 |
8.932400E-02 |
| N0-vs-N2 |
2.662800E-01 |
| N1-vs-N2 |
1.788610E-01 |
|
|
